Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements (Tables)

v3.23.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Measurements  
Schedule of company's assets that are measured at fair value on a recurring basis

    

Fair Value Measured as of December 31, 2022

Quoted Prices in

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

 

  

 

  

 

  

Investments held in Trust Account

$

420,092,302

$

$

Liabilities:

 

  

 

  

 

  

Derivative warrant liabilities - Public Warrant

$

1,035,000

$

$

Derivative warrant liabilities - Private Placement Warrant

$

$

$

514,000

Fair Value Measured as of December 31, 2021

Significant Other

    

Quoted Prices in

    

Significant Other

    

Unobservable

Active Markets

Observable Inputs

Inputs

Description

(Level 1)

(Level 2)

(Level 3)

Assets:

Investments held in Trust Account

$

414,023,891

$

$

Liabilities:

Derivative warrant liabilities - Public warrant

$

11,592,000

$

$

Derivative warrant liabilities - Private warrant

$

$

$

5,756,800

Schedule of change in the fair value of the warrant liabilities

Derivative warrant liabilities at January 1, 2021

    

$

Issuance of Public and Private Warrants - Level 3

 

21,272,000

Transfer of Public Warrants to Level 1 Measurement

(14,076,000)

Change in fair value of derivative warrant liabilities - Level 3

(1,439,200)

Derivative warrant liabilities at December 31, 2021 - Level 3

$

5,756,800

Change in fair value of derivative warrant liabilities - Level 3

(5,242,800)

Derivative warrant liabilities at December 31, 2022 - Level 3

$

514,000

Schedule of quantitative information regarding Level 3 fair value measurements inputs

December 31, 

    

2022

    

2021

  

Exercise price

$

11.50

$

11.50

Volatility

5.50

%  

10.00

%

Stock price

$

10.11

$

9.73

Expected life of the options to convert

5.19

5.61

Risk-free rate

3.91

%  

1.31

%

Implied Success

5.40

%  

N/A